Metabolic-associated fatty liver disease (MAFLD) has been identified as risk factor of
incident type 2 diabetes (T2D), but the underlying postprandial mechanisms remain unclear …

OBJECTIVE Prediabetes and type 2 diabetes mellitus (T2DM) are believed to be common
and associated with a worse metabolic profile in patients with nonalcoholic fatty liver …

Background & Aims Non-alcoholic fatty liver disease (NAFLD) is associated with abnormal
mitochondrial capacity. While oxidative capacity can be increased in steatosis, hepatic ATP …

Aims To investigate the association between overweight/obesity and fatty liver index (FLI) on
the odds of incident prediabetes/type 2 diabetes and non-alcoholic fatty liver disease …

Context: Nonalcoholic fatty liver disease (NAFLD) is associated with glucose and lipid
metabolic abnormalities. However, insulin suppression of very low-density lipoprotein …

Background. Few studies have investigated the epidemiological metabolic (dysfunction)
associated with fatty liver disease (MAFLD) in China, especially among those with type 2 …

Background Progressive overloads of intrahepatic triglycerides are related to metabolic
dysregulation of multiple lipid and lipoprotein profiles, but whether similar dose effects are …

Objectives: Patients with type 1 diabetes mellitus (T1DM) lack the portal/peripheral insulin
gradient, which might diminish insulin stimulation of hepatic lipogenesis and protect against …

Metabolic dysfunction and nonalcoholic fatty liver disease r... : Current Opinion in
Gastroenterology Metabolic dysfunction and nonalcoholic fatty liver disease risk in individuals …

Aim We examined whether different insulin administration modalities, ie, multiple daily
injections (MDI) or continuous subcutaneous insulin infusion (CSII by insulin pumps), are …